Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery

Journal of Heart Valve Disease

Volumn 19, Issue 3, 2010, Pages 333-340

  Kim, So Yeon ^a   Shim, Jae Kwang ^a   Shim, Yeon Hee ^a   Hong, Seong Wook ^b   Choi, Kil Hwan ^a   Kwak, Young Lan ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Gyungbook University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; BERASIL; PLACEBO; SILDENAFIL; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PIPERAZINE DERIVATIVE; PROSTACYCLIN; PURINE DERIVATIVE; SULFONE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANESTHESIA INDUCTION; ARTERIAL OXYGEN TENSION; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL EVALUATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; GENERAL ANESTHESIA; HEART EJECTION FRACTION; HEART RATE; HEART VALVE SURGERY; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PATIENT MONITORING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; ADULT; AGED; BLOOD PRESSURE; COMORBIDITY; DRUG COMBINATION; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREOPERATIVE CARE; VALVULAR HEART DISEASE; VASCULAR RESISTANCE;

ADULT; AGED; ANESTHESIA, GENERAL; BLOOD PRESSURE; COMORBIDITY; DRUG THERAPY, COMBINATION; EPOPROSTENOL; FEMALE; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PIPERAZINES; PREOPERATIVE CARE; PURINES; SULFONES; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 77954896865     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999;89:814-822 (Pubitemid 29458450)
2. Fischer LG, Van Aken H, Burkle H. Management of pulmonary hypertension: Physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003;96:1603-1616 (Pubitemid 36623112)
3. Shim JK, Choi YS, Oh YJ, Kim DH, Hong YW, Kwak YL. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery. J Thorac Cardiovasc Surg 2006;132:1420-1425
4. Barst RJ, McGoon M, McLaughlin V, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:2119-2125 (Pubitemid 36724255)
5. Ghofrani HA, Schermuly RT, Rose F, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003;167:1139-1141 (Pubitemid 36459662)
6. Ikeda D, Tsujino I, Ohira H, et al. Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension. J Cardiovasc Pharmacol 2005;45:286-289
7. Nagaya N, Uematsu M, Okano Y, et al. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. J Am Coll Cardiol 1999;34:1188-1192
8. Sastry BK, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 2004;43:1149-1153 (Pubitemid 38452588)
9. Trachte AL, Lobato EB, Urdaneta F, et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 2005;79:194-197
10. Miyata M, Ueno Y, Sekine H, et al. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension. J Cardiovasc Pharmacol 1996;27:20-26
11. Rossi R, Nuzzo A, Lattanzi A, Coppi F, Modena MG. Sildenafil improves endothelial function in patients with pulmonary hypertension. Pulm Pharmacol Ther 2008;21:172-177
12. Winterhalter M, Simon A, Fischer S, et al. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: A prospective randomized trial. J Cardiothorac Vasc Anesth 2008;22:406-413
13. Mangano DT. Biventricular function after myocardial revascularization in humans: Deterioration and recovery patterns during the first 24 hours. Anesthesiology 1985;62:571-577
14. Ghofrani HA, Rose F, Schermuly RT, et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 2003;42:158-164
15. Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002;136:515-522
16. Schroeder RA, Kuo PC. Nitric oxide: Physiology and pharmacology. Anesth Analg 1995;81:1052-1059
17. Ghofrani HA, Wiedemann R, Rose F, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 2002;360:895-900
18. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-75
19. Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 1999;159:1925-1932
20. Bhatia S, Frantz RP, Severson CJ, Durst LA, McGoon MD. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Mayo Clin Proc 2003;78:1207-1213 (Pubitemid 37193511)
21. Durongpisitkul K, Laoprasitiporn D, Layangool T, Sittiwankul R, Panamonta M, Mokrapong P. Comparison of the acute pulmonary vasodilating effect of beraprost sodium and nitric oxide in congenital heart disease. Circ J 2005;69:61-64
22. Lepore JJ, Maroo A, Bigatello LM, et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: Combined administration with inhaled nitric oxide. Chest 2005;127:1647-1653
23. Ono F, Nagaya N, Kyotani S, Oya H, Nakanishi N, Miyatake K. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension. Circ J 2003;67:375-378 (Pubitemid 36554055)
24. Cheitlin MD, Hutter AM, Jr., Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation 1999;99:168-177
25. Hoeper MM, Galie N, Simonneau G, Rubin LJ. New treatments for pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165:1209-1216 (Pubitemid 34461731)
26. Galie N, Humbert M, Vachiery JL, et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002;39:1496-1502
27. Muirhead GJ, Rance DJ, Walker DK, Wastall P. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil. Br J Clin Pharmacol 2002;53(Suppl.1):13S-20S (Pubitemid 34226982)
28. Madden BP, Sheth A, Ho TB, Park JE, Kanagasabay RR. Potential role for sildenafil in the management of perioperative pulmonary hypertension and right ventricular dysfunction after cardiac surgery. Br J Anaesth 2004;93:155-156
29. Ichinose F, Erana-Garcia J, Hromi J, et al. Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med 2001;29:1000-1005
30. Itoh T, Nagaya N, Fujii T, et al. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med 2004;169:34-38
31. Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol 2002;283:H1263-H1269
32. Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 2007;175:846-850 (Pubitemid 46631797)
33. Raja SG, Danton MD, MacArthur KJ, Pollock JC. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects. J Cardiothorac Vasc Anesth 2007;21:203-207